FOXP3 and allergic disease: In addition, allergy immunotherapy led to a significant decrease in ER stress and PERK/CHOP signaling, increasing CD4+CD25+Foxp3+ Treg cells, and ameliorated airway hyper-responsiveness and airway inflammation.